Medical Devices; Cardiovascular Devices; Classification of the Infant Pulse Rate and Oxygen Saturation Monitor for Over-the-Counter Use
By Health, Drug Administration, Human Services Department, Food · Oct 8, 2026, 11:00 PM CDT
The Food and Drug Administration (FDA) is classifying the infant pulse rate and oxygen saturation monitor for over-the-counter use into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the infant pulse rate and oxygen saturation monitor for over-the-counter use. We are taking
Excerpt shown under fair-use limits. Full text remains with the original publisher.
People in this coverage
Explore their history and attributable record. Being mentioned does not imply endorsement.
Layer 1 · Claims & fact checks
AI analysisLayer 3 · Reporting analysis
AI analysisFramingThe agency frames the classification as a protective measure for safety and effectiveness, emphasizing a positive impact on patient access.
LanguageThe use of words like "enhance" and "reduce regulatory burdens" presents the decision in a favorable light, suggesting benefits beyond safety.
Context
AI analysisMissing context
The announcement does not provide details about the specific special controls that will apply, the timeline for implementation, how the classification compares to existing similar devices, or any input from manufacturers, clinicians, or consumer groups.
Important context
Class II designation by the FDA indicates that a device is subject to special controls in addition to general controls, which typically include performance standards, post‑market surveillance, and labeling requirements. This classification can affect market entry, reimbursement, and regulatory oversight.
Opinion vs. reporting
AI analysisThe text presents factual statements from the FDA without expressing opinion; it is primarily reporting the agency's classification decision.